Vivos Inc (RDGL)

[kayak_wench]

You are wrong. If they had focused 100% on IDE submission and ignored IsoPet they would not
- have proven treatment is effective years after single use (or do you expect them to follow rabbits for years...)
- had not learned the importance and size of margins to treat to minimize reoccurance
- would have zero experience in treating very large tumors and the need to follow up with removal of excess dead tissue
- have zero experience in understanding the VARIOUS ways treated areas heal and nature of long-term scarring and skin damage
- have zero experience with treating mast tumors (which by the way was a success)
- have very little experience with how different people prefer to hold and handle syringe and supporting equipment (real world feedback from range of people, young, old, male, female)
- have very little zero experience with training people to become familar with the product
- have zero experience with getting clinics licensed to handle the product.

I could go on but I don't see the point as I do not think you will change your opinion.